Advanced Biomedical Technologies Stock Probability of Future Pink Sheet Price Finishing Under 0.00
Advanced Biomedical's future price is the expected price of Advanced Biomedical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Advanced Biomedical Technologies performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please specify Advanced Biomedical's target price for which you would like Advanced Biomedical odds to be computed.
Advanced |
Advanced Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Advanced Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Advanced Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Advanced Biomedical is not yet fully synchronised with the market data | |
| Advanced Biomedical generated a negative expected return over the last 90 days | |
| Advanced Biomedical has high historical volatility and very poor performance | |
| Advanced Biomedical has some characteristics of a very speculative penny stock | |
| Advanced Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K. |
Advanced Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Advanced Pink Sheet often depends not only on the future outlook of the current and potential Advanced Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Advanced Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 70.1 M | |
| Cash And Short Term Investments | 201.7 K |
Advanced Biomedical Technical Analysis
Advanced Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Advanced Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Advanced Biomedical Technologies. In general, you should focus on analyzing Advanced Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Advanced Biomedical Predictive Forecast Models
Advanced Biomedical's time-series forecasting models is one of many Advanced Biomedical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Advanced Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Advanced Biomedical
Checking the ongoing alerts about Advanced Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Advanced Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Advanced Biomedical generated a negative expected return over the last 90 days | |
| Advanced Biomedical has high historical volatility and very poor performance | |
| Advanced Biomedical has some characteristics of a very speculative penny stock | |
| Advanced Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Advanced Biomedical Technologies currently holds 6.36 M in liabilities. Advanced Biomedical has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Advanced Biomedical until it has trouble settling it off, either with new capital or with free cash flow. So, Advanced Biomedical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Advanced Biomedical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Advanced to invest in growth at high rates of return. When we think about Advanced Biomedical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 123.59 K. Net Loss for the year was (672 K) with profit before overhead, payroll, taxes, and interest of 71.77 K. |
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.